Jennifer McWilliams
Acute Care · Halls, TNNPI 1720289143
Payments from drug & device makers
Across 200 payments — averaging $14.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$772
- AbbVie$743
- AstraZeneca$450
- Amgen$145
- GSK$128
- Biohaven Pharmaceutical Holding Company Ltd.$122
- plus $574 from 12 others
What the payments were for
- Food & beverage$2,934100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 60 | $772 |
| AbbVie | 68 | $743 |
| AstraZeneca | 21 | $450 |
| Amgen | 9 | $145 |
| GSK | 5 | $128 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $122 |
| Axsome Therapeutics, Inc. | 4 | $118 |
| Pfizer | 4 | $96 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $71 |
| Phathom Pharmaceuticals, Inc. | 4 | $56 |
| Exact Sciences | 3 | $53 |
| Lilly USA, LLC | 3 | $52 |
| Bayer | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $15 |
| Abbott | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Novartis | 1 | $13 |
How this compares
$2,934 in reported general payments places this provider in the 85th percentile of 738 acute care providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 137 | $146,838 |
| FarxigaDapagliflozin Propanediol | 142 | $100,032 |
| MounjaroTirzepatide | 85 | $89,995 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 114 | $76,404 |
| EliquisApixaban | 58 | $46,981 |
| JardianceEmpagliflozin | 72 | $45,133 |
| TradjentaLinagliptin | 54 | $43,241 |
| LinzessLinaclotide | 64 | $41,642 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 37 | $24,835 |
| TrulicityDulaglutide | 16 | $20,050 |
| XareltoRivaroxaban | 32 | $19,038 |
| Repatha SureclickEvolocumab | 17 | $11,267 |
| Bydureon BciseExenatide Microspheres | 13 | $10,074 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 16 | $7,491 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $6,112 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $772 | $146,838137 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $450 | $124,867179 claims |
| Lilly USA, LLCMounjaro, Trulicity | $52 | $110,045101 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $128 | $90,006146 claims |
| PfizerEliquis, Abrysvo | $96 | $50,63670 claims |
| AbbVieLinzess, Synthroid | $743 | $43,29287 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 738 acute care providers in Tennessee.
Other acute care in Halls
- Haley HoyNashville$368K
- Anne AlexandrovMemphis$110K
- Stephen MillerKnoxville$108K
- Shannon GraceNashville$57K
- Timothy BallardKnoxville$47K
- Kelsey MartinNashville$42K
- Barbara BrownNashville$36K
- Michelle GoochChattanooga$35K
- Elizabeth DavidsonNashville$33K
- Kelly JacksonMurfreesboro$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.